Medicare Enrolled

Dr. Ahmet Ergin, M.D.

Endocrinology · Port St Lucie, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1400 SE GOLDTREE DR STE 102-104, Port St Lucie, FL 34952
7723987814
In practice since 2009 (16 years)
NPI: 1023247111 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ergin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ergin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ergin

Dr. Ahmet Ergin is an endocrinology specialist in Port St Lucie, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Ergin performed 2,336 Medicare services across 1,149 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ergin received a total of $653,947 from 53 pharmaceutical and/or device companies across 1910 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ergin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 25% volume in FL $653,947 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,336
Medicare services
Top 25% in FL for endocrinology
1,149
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~146 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 1,356 $94 $225
Blood draw (venipuncture) 324 $8 $9
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 310 $27 $136
New patient office visit (45-59 min) 188 $114 $358
Office visit, established patient (20-29 min) 53 $68 $153
Ultrasound scan of head and neck soft tissue 48 $59 $387
Hemoglobin A1c test (diabetes monitoring) 34 $10 $41
Fine needle aspiration biopsy using ultrasound guidance, first growth 23 $99 $420
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$653,947
Total received (2018-2024)
Avg $93,421/year across 7 years
Top 2% in FL for endocrinology
53
Companies
1,910
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$639,532 (97.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,415 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$24,487
2023
$39,772
2022
$103,077
2021
$78,812
2020
$75,096
2019
$156,291
2018
$176,412

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$352,775
Lilly USA, LLC
$164,680
Bayer Healthcare Pharmaceuticals Inc.
$37,731
Bayer HealthCare Pharmaceuticals Inc.
$31,216
Boehringer Ingelheim Pharmaceuticals, Inc.
$25,721
AstraZeneca Pharmaceuticals LP
$20,010
SANOFI-AVENTIS U.S. LLC
$9,841
Medtronic, Inc.
$2,572
Mannkind Corporation
$1,189
Abbott Laboratories
$1,045
Medtronic MiniMed, Inc.
$1,001
Tandem Diabetes Care, Inc.
$537
Esperion Therapeutics, Inc.
$475
Insulet Corporation
$471
Amgen Inc.
$451
MannKind Corporation
$425
IBSA Pharma Inc.
$344
Xeris Pharmaceuticals, Inc.
$340
Horizon Therapeutics plc
$290
ABBVIE INC.
$282
Janssen Pharmaceuticals, Inc
$266
Merck Sharp & Dohme Corporation
$265
Dexcom, Inc.
$259
Becton, Dickinson and Company
$167
Antares Pharma, Inc.
$153
AbbVie Inc.
$138
Novartis Pharmaceuticals Corporation
$138
RECORDATI_RARE_DISEASES_INC.
$123
Janssen Scientific Affairs, LLC
$98
Astellas Pharma US Inc
$98
Corcept Therapeutics
$93
Embecta Corp.
$82
Amphastar Pharmaceuticals, Inc.
$81
DEXCOM, INC.
$65
Amneal Pharmaceuticals LLC
$65
AbbVie, Inc.
$64
Amarin Pharma Inc.
$63
Shire North American Group Inc
$40
Senseonics, Incorporated
$38
GRT US Holding, Inc.
$32
BETA BIONICS, INC.
$26
EUSA Pharma (US) LLC
$22
Neurocrine Biosciences, Inc.
$20
VIVUS LLC
$20
Ultragenyx Pharmaceutical Inc.
$19
Merck Sharp & Dohme LLC
$17
Acella Pharmaceuticals, LLC
$17
Ipsen Biopharmaceuticals, Inc
$16
Relypsa, Inc.
$14
CeQur Corporation
$14
Alfasigma USA, Inc.
$13
Amryt Pharma Holdings Ltd
$13
VistaPharm, Inc.
$12
Top 3 companies account for 84.9% of total payments
Associated products mentioned in payments ›
AFREZZA · AVEIR · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DISEASE STATE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Freedom Lite system · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GUARDIAN CONNECT · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · MINIMED 770G · MINIMED 780G · MYCAPSSA · Minimed 630G · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · NP Thyroid 60 · NovoLog · OTREXUP · Omnipod · Ozempic · Prolia · Qsymia · Qutenza · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIA · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · SYNJARDY · SYNTHROID · Saxenda · Somatuline Depot · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · UBRELVY · UNITHROID · Vascepa · Veltassa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for endocrinology in FL.

Equivalent to $27,994 per 100 Medicare services performed
Looking for an endocrinology specialist in Port St Lucie?
Compare endocrinologists in the Port St Lucie area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
9
Per 100K population
2.6
County median income
$69,027
Nearest hospital
ST LUCIE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ergin is a clinical cardiology specialist, with above-average Medicare volume (top 25% in FL), with speaking/promotional industry engagement in the top 2% of FL peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ergin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ergin performed 1,356 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ergin receive payments from pharmaceutical companies?
Yes. Dr. Ergin received a total of $653,947 from 53 companies across 1,910 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ergin's costs compare to other endocrinologists in Port St Lucie?
Dr. Ergin's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ergin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →